Malattia di Castleman: chi è costei?

Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956;9:822–30. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670–83. Dégot T, Métivier AC, Casnedi S, Chenard MP, Kessler R. Thoracic manifestations of Castleman's disease. Rev Pneumol Clin 2009;65:101–7. Papaziogas B, Chatzimavroudis G, Koutelidakis I et al. A rare form of isolated mesenteric Castleman's disease presenting as an abdominal mass (isolated mesenteric Castleman's disease). J Gastrointestin Liver Dis 2006;15:171-4. McAdams HP, Rosado-de-Christenson M, Fishback NF, Templeton PA. Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation. Radiology 1998;209:221–8 Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998;128(8):657–62. Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest. 1990;86(2):592–9. Dupin N, Diss TL, Kellam P et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95(4):1406–12. Leroy S, Moshous D, Cassar O, et al Multicentric Castleman disease in an HHV-8-infected child born to consanguineous parents. Pediatrics. 2012;129(1):e199-203. Modi P, Trivedi A, Gupta R et al. Retroperitoneal pararenal Castleman's tumor in an adolescent managed laparoscopically. J Endourol. 2008;22:2451-4. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer 1999;85:706-17. Farruggia P, Trizzino A, Scibetta N, Cecchetto G, Guerrieri P, D'Amore ESG, D'Angelo P. Castleman's disease in childhood: report of three cases and review of the literature. Ital J Pediatr. 2011;37:50. Bower M, Veraitch O, Szydlo R, et al. Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease. Blood 2009;113(19):4521–4. van Rhee F, Fayad L, Voorhees P, et al.. Siltuximab, a Novel Anti-Interleukin-6 Monoclonal Antibody, for Castleman's Disease. J Clin Oncol 2010;28(23):3701–08. Galeotti C, Tran TA, Franchi-Abella S, Fabre M, Pariente D, Koné-Paut I. IL-1RA agonist (anakinra) in the treatment of multifocal Castleman disease: case report. J Pediatr Hematol Oncol 2008;30(12):920–4.